| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/22/2009 | WO2009062506A1 Methods of quantification for lateral flow devices |
| 05/22/2009 | WO2009062497A2 Method for end-titre determination and the evaluation thereof by means of an indirect immunofluorescence assay |
| 05/22/2009 | WO2009062470A1 Use of nanopatterned surfaces and method for enriching or isolating cellular subpopulations |
| 05/22/2009 | WO2009062465A1 Method and device for determining 14c in solid and liquid samples |
| 05/22/2009 | WO2009062309A1 Methods for the regulation of the prostaglandin f synthase (pgfs) activity of akr1b1 and uses thereof |
| 05/22/2009 | WO2009046291A3 Laboratory-selected colonies of western corn rootworm with increased tolerance to maize containing event das-59122-7 and methods of use |
| 05/22/2009 | WO2009046136A3 Microfluidic integration with nanosensor platform |
| 05/22/2009 | WO2009045448A3 Gas measuring device and method of manufacturing the same |
| 05/22/2009 | WO2009045377A3 A non-desensitizing mutant of the transient receptor potential trpm5 ion channel |
| 05/22/2009 | WO2009042163A3 Rapid in vivo identification of biologically active nucleases |
| 05/22/2009 | WO2009040508A3 Methods of detection and enrichment of prpsc by immunoprecipitation and elisa |
| 05/22/2009 | WO2009035929A3 Cardiovascular and brain cell therapy using intracellular ryanodine receptor modulation by the estrogen receptor beta |
| 05/22/2009 | WO2009035412A8 Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof |
| 05/22/2009 | WO2009035357A3 Immunological tests for the presence of bacteria which make use of antibodies obtained using a specific method |
| 05/22/2009 | WO2009033163A3 Borrelia diagnostics and screening methods |
| 05/22/2009 | WO2009026605A3 Set of tumour-markers |
| 05/22/2009 | WO2009025894A3 Smartcard chemical, biological, radiation and explosive detector |
| 05/22/2009 | WO2009024691A3 Method of assaying leukocyte elastase inhibitor for the in vitro diagnosis of colorectal cancer |
| 05/22/2009 | WO2009021240A3 Sensing and identifying biological sampels on microfluidic devices |
| 05/22/2009 | WO2009013637A3 Method and device for assessing carbohydrate-to-insulin ratio |
| 05/22/2009 | WO2009009424A3 Rapid generation of t cell-independent antibody responses to t cell-dependent antigens |
| 05/22/2009 | WO2009005871A3 Novel optical labeling molecules in proteomics and other biological analyses |
| 05/22/2009 | WO2009001222A3 METHOD FOR SCREENING FOR SELECTIVE MODULATOR OF THE NF-ϰB PATHWAY ACTIVATION |
| 05/22/2009 | WO2008152448A3 Streptococcus proteins, and their use in vaccination |
| 05/22/2009 | WO2008152446A3 Novel glycosylated peptide target in neoplastic cells |
| 05/22/2009 | WO2008089994A8 Use of igfbp-7 in the assessment of heart failure |
| 05/22/2009 | WO2008068428A3 Cosmetic use of chitinase-type proteins<0} |
| 05/22/2009 | WO2008067497A9 Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same |
| 05/22/2009 | WO2007050100A3 Immobilized enzymes and processes for preparing and using same |
| 05/22/2009 | WO2007041623A3 Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes |
| 05/22/2009 | WO2006127865A3 Bioresponsive hydrogels |
| 05/22/2009 | WO2006111967A3 Method for augmenting the ability of t-cells and other cells for fighting disease and invade diseased organs, for elevating cd3 zeta and tnf-alpha expression in t-cells, and mixing t-cell boosting devices and kit particularly useful in such method |
| 05/22/2009 | WO2006110593A3 Biological targets for the diagnosis, treatment and prevention of cancer |
| 05/22/2009 | WO2002057787A9 Detection of survivin in the biological fluids of cancer patients |
| 05/22/2009 | CA2743334A1 Methods relating to breathing disorders |
| 05/22/2009 | CA2719103A1 Biomarker detection |
| 05/22/2009 | CA2705923A1 Antibodies to lrp6 |
| 05/22/2009 | CA2705841A1 Mammalian artificial chromosome vector comprising human cytochrome p450 gene (cluster) and non-human mammalian animal retaining the same |
| 05/22/2009 | CA2705765A1 Method of efficient extraction of protein from cells |
| 05/22/2009 | CA2705750A1 Instrument for use with fluid |
| 05/22/2009 | CA2705741A1 Method for monitoring the use of consumables of a disposable type in one or more analysis devices |
| 05/22/2009 | CA2705582A1 Antibodies specific for the protofibril form of beta-amyloid protein |
| 05/22/2009 | CA2705555A1 Compositions and methods for the therapy and diagnosis of influenza |
| 05/22/2009 | CA2705509A1 Diagnosis and treatment of cancer using anti-gpr49 antibody |
| 05/22/2009 | CA2705506A1 Maldi matrix and maldi method |
| 05/22/2009 | CA2705432A1 Protease detection |
| 05/22/2009 | CA2705376A1 Methods for the regulation of the prostaglandin f synthase (pgfs) activity of akr1b1 and uses thereof |
| 05/22/2009 | CA2705272A1 Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside |
| 05/22/2009 | CA2702421A1 Method for end-titre determination and the evaluation thereof by means of an indirect immunofluorescence assay |
| 05/22/2009 | CA2701339A1 Mycophenolic acid immunogens and antibodies |
| 05/21/2009 | US20090133163 Promoter, promoter control elements, and combinations, and uses thereof |
| 05/21/2009 | US20090133135 Diagnostic and Therapeutic Target SLC39A11 Proteins for Neurodegenerative Diseases |
| 05/21/2009 | US20090133133 Transgenic Mice for Bioassay of Prions from Deer and Elk with Chronic Wasting Disease |
| 05/21/2009 | US20090132465 System for animal health diagnosis |
| 05/21/2009 | US20090132174 Seafood physical characteristic estimation system and method |
| 05/21/2009 | US20090132171 Screening Method for Specific Protein in Proteome Comprehensive Analysis |
| 05/21/2009 | US20090131965 Tissue penetration device |
| 05/21/2009 | US20090131964 Tissue penetration device |
| 05/21/2009 | US20090131830 Method and Apparatus for Penetrating tissue |
| 05/21/2009 | US20090131773 Sensor for Detection of Carbohydrate |
| 05/21/2009 | US20090131682 Supports for oligomer synthesis |
| 05/21/2009 | US20090131675 Methods for structural analysis of proteins |
| 05/21/2009 | US20090131524 Sialic acid abc transporters in prokaryotes therapeutic targets |
| 05/21/2009 | US20090131502 Biologically active compounds |
| 05/21/2009 | US20090131478 Growth Hormone Secretagogues |
| 05/21/2009 | US20090131451 Diagnosis and treatment of type 2 diabetes and other disorders |
| 05/21/2009 | US20090131390 FK 228 derivates as HDAC inhibitors |
| 05/21/2009 | US20090131361 Novel Use of MLN51 Gene and Protein |
| 05/21/2009 | US20090131346 Antibody and method for identification of dendritic cells |
| 05/21/2009 | US20090131327 Nogo receptor functional motifs and peptide mimetics related thereto and methods of using the same |
| 05/21/2009 | US20090131278 Non-specific binding resistant protein arrays and methods for making the same |
| 05/21/2009 | US20090131277 Prostate cancer diagnosis and treatment |
| 05/21/2009 | US20090131267 Use of polymers for increasing the signal intensity when carrying out detection reactions |
| 05/21/2009 | US20090130778 Water-Soluble Polymeric Substrate Having Metallic Nanoparticle Coating |
| 05/21/2009 | US20090130777 Method for evaluating analyte |
| 05/21/2009 | US20090130776 Binding protein molecule |
| 05/21/2009 | US20090130775 ulcerative colitis; setting a base value of a main metabolite of prostaglandin, 7 alpha -hydroxy-5,11-diketotetranor-prosta-1,16-dioic acid (PGE-MUM), concentration in urine |
| 05/21/2009 | US20090130774 Elisa assays using prion-specific peptide reagents |
| 05/21/2009 | US20090130770 Biomarker for farnesyl pathway |
| 05/21/2009 | US20090130769 Novel Cross-Linkers For Obtaining Structure Information On Molecule Complexes |
| 05/21/2009 | US20090130768 Vapochromic coordination polymers for use in analyte detection |
| 05/21/2009 | US20090130767 Organosilanes and substrates covalently bonded with same and methods for synthesis and use |
| 05/21/2009 | US20090130766 Fluid sample transport device with reduced dead volume for processing, controlling and/or detecting a fluid sample |
| 05/21/2009 | US20090130744 Apparatus and method to measure platelet contractility |
| 05/21/2009 | US20090130719 Microfluidic Cartridge |
| 05/21/2009 | US20090130696 HDL Cholesterol Sensor Using Selective Surfactant |
| 05/21/2009 | US20090130695 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase; antitumor agents, anticancer agents |
| 05/21/2009 | US20090130694 MAC-2BP as a Marker for the Diagnosis of Gastric Cancer |
| 05/21/2009 | US20090130693 Novel biomarkers for diagnosis and/or prognosis of neoplasias in animals |
| 05/21/2009 | US20090130692 Use of microproteins as tryptase |
| 05/21/2009 | US20090130691 Screening proteinase modulators using a chimeric protein and ski-i proprotein convertase substrates and inhibitors |
| 05/21/2009 | US20090130690 Method for the diagnosis of rheumatoid arthritis |
| 05/21/2009 | US20090130689 Method useful for detecting encephalopathies |
| 05/21/2009 | US20090130681 21132, a Human G-protein coupled receptor family member and uses therefor |
| 05/21/2009 | US20090130678 Methods and Kits for Breast Cancer Prognosis |
| 05/21/2009 | US20090130676 Interaction trap systems for detecting protein interactions |
| 05/21/2009 | US20090130662 Method for Diagnosis of Prostate Cancer |
| 05/21/2009 | US20090130659 Kits and methods for detecting methylated dna |
| 05/21/2009 | US20090130655 Detection method using nanoaggregate-embedded beads and system thereof |
| 05/21/2009 | US20090130653 Interference Control Panel for Evaluation of Analytical Assays for Samples Derived from Blood |